Using a less specific marker, i.e., CD14 (monocyte/macrophage), Gannot et al. [48] could observe a trend of an increased number of CD14+ cells from normal to PMDs, but the findings were not statistically significant and the CD14+ cells were actually reduced in tumor samples. The gene discussed is CD14; the disease is neoplasm.